Quince Therapeutics (QNCX) News
NASDAQ: QNCXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
QNCX news summary
We found 2 recent headlines mentioning Quince Therapeutics (QNCX): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. QNCX is making an outsized move today, up 8.07% at $31.73, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Raymond James Initiates Coverage of Quince Therapeutics at Outperform", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Quince Therapeutics headlines
- Raymond James Initiates Coverage of Quince Therapeutics at OutperformFintel reports that on October 9, 2026, Raymond James initiated coverage of Quince Therapeutics (NASDAQGS:QNCX) with a Outperform recommendation. On the day of this rating action, October 9, 2026,…NasdaqQNCX, BRK.B
- Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary DiseaseCompany common stock to trade on Nasdaq under the symbol “IRLA” effective October 12, 2026GlobeNewswire